134 related articles for article (PubMed ID: 16023597)
1. A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
Loeb KR; Kostner H; Firpo E; Norwood T; D Tsuchiya K; Clurman BE; Roberts JM
Cancer Cell; 2005 Jul; 8(1):35-47. PubMed ID: 16023597
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
3. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
4. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland.
Smith AP; Henze M; Lee JA; Osborn KG; Keck JM; Tedesco D; Bortner DM; Rosenberg MP; Reed SI
Oncogene; 2006 Nov; 25(55):7245-59. PubMed ID: 16751806
[TBL] [Abstract][Full Text] [Related]
5. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
6. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E in normal and neoplastic cell cycles.
Hwang HC; Clurman BE
Oncogene; 2005 Apr; 24(17):2776-86. PubMed ID: 15838514
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure during sepsis: potential role of cell cycle regulation.
Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
10. Isokotomolide A, a new butanolide extracted from the leaves of Cinnamomum kotoense, arrests cell cycle progression and induces apoptosis through the induction of p53/p21 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells.
Chen CY; Hsu YL; Chen YY; Hung JY; Huang MS; Kuo PL
Eur J Pharmacol; 2007 Nov; 574(2-3):94-102. PubMed ID: 17707793
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
13. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
14. p53 and p21 regulate error-prone DNA repair to yield a lower mutation load.
Avkin S; Sevilya Z; Toube L; Geacintov N; Chaney SG; Oren M; Livneh Z
Mol Cell; 2006 May; 22(3):407-13. PubMed ID: 16678112
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.
Vormer TL; Foijer F; Wielders CL; te Riele H
Mol Cell Biol; 2008 Dec; 28(24):7263-73. PubMed ID: 18936168
[TBL] [Abstract][Full Text] [Related]
17. Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.
Efeyan A; Collado M; Velasco-Miguel S; Serrano M
Oncogene; 2007 Mar; 26(11):1645-9. PubMed ID: 16964282
[TBL] [Abstract][Full Text] [Related]
18. p21 stability: linking chaperones to a cell cycle checkpoint.
Liu G; Lozano G
Cancer Cell; 2005 Feb; 7(2):113-4. PubMed ID: 15710322
[TBL] [Abstract][Full Text] [Related]
19. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
[TBL] [Abstract][Full Text] [Related]
20. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
